Chinese Co. Northeast Settles Vitamin C Antitrust Claims

Law360, New York (April 2, 2013, 4:14 PM EDT) -- Northeast Pharmaceutical Group Co. Ltd. filed a settlement Monday with indirect purchasers in multidistrict antitrust litigation over alleged price-fixing by vitamin C producers, ending the Chinese company's involvement in the sprawling New York case.

Northeast will pay a class of indirect purchasers $500,000 to resolve claims that class members paid inflated prices for vitamin C because the Chinese company colluded with other producers to inflate the prices. The agreement came a week after Northeast inked a similar, $500,000 deal with a so-called injunction class.

Compared to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.